Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
How huntingtin (HTT) triggers neurotoxicity in Huntington’s disease (HD) remains unclear. We report that HTT forms a transcription-coupled DNA repair (TCR) complex with RNA polymerase II subunit A (POLR2A), ataxin-3, the DNA repair enzyme polynucleotide-kinase-3'-phosphatase (PNKP), and cyclic AMP-response element-binding (CREB) protein (CBP). This complex senses and facilitates DNA damage repair during transcriptional elongation, but its functional integrity is impaired by mutant HTT. Abrogated PNKP activity results in persistent DNA break accumulation, preferentially in actively transcribed genes, and aberrant activation of DNA damage-response ataxia telangiectasia-mutated (ATM) signaling in HD transgenic mouse and cell models. A concomitant decrease in Ataxin-3 activity facilitates CBP ubiquitination and degradation, adversely impacting transcription and DNA repair. Increasing PNKP activity in mutant cells improves genome integrity and cell survival. These findings suggest a potential molecular mechanism of how mutant HTT activates DNA damage-response pro-degenerative pathways and impairs transcription, triggering neurotoxicity and functional decline in HD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
PUMA, a Novel Proapoptotic Gene, Is Induced by p53
Nakano, K., & Vousden, K. H. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00214-3 · Cited by 2,315
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112 · cited 1×
“In response to DNA strand break accumulations, ATM is activated by phosphorylation which phosphorylates p53, which in turn activates pro-apoptotic gene transcription (Chipuk et al., 2004; Nakano and Vousden, 2001; Oda et al., 2000).”
BackgroundDirect Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108 · cited 1×
“In response to DNA strand break accumulations, ATM is activated by phosphorylation which phosphorylates p53, which in turn activates pro-apoptotic gene transcription (Chipuk et al., 2004; Nakano and Vousden, 2001; Oda et al., 2000).”
BackgroundActivity-Induced DNA Breaks Govern the Expression of Neuronal Early-Response Genes
Madabhushi, R., Gao, F., Pfenning, A. R., Pan, L., Yamakawa, S., Seo, J., Rueda, R., Phan, T. X., Yamakawa, H., Pao, P.-C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.032 · Cited by 700
Disruption of CREB function in brain leads to neurodegeneration
Mantamadiotis, T., Lemberger, T., Bleckmann, S. C., Kern, H., Kretz, O., Villalba, A. M., Tronche, F., Kellendonk, C., Gau, D., Kapfhammer, J., et al. (2002) · Nature Genetics · doi:10.1038/ng882 · Cited by 684
Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease
Lee, J.-M., Wheeler, V. C., Chao, M. J., Vonsattel, J. P. G., Pinto, R. M., Lucente, D., Abu-Elneel, K., Ramos, E. M., Mysore, J. S., Gillis, T., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.003 · Cited by 655 · cited 1×
“Given that HTT interacts with huntingtin-associated protein 1 (HAP-1; Li et al., 1995), while ATXN3 interacts with HAP-1 (Takeshita et al., 2011) and PNKP (Chatterjee et al., 2015; Gao et al., 2015), we asked whether ATXN3 and PNKP might interact with HTT to form a TCR complex and if this is…”
BackgroundDNA damage and its links to neurodegeneration
Madabhushi, R., Pan, L., & Tsai, L.-H. (2014) · Neuron · doi:10.1016/j.neuron.2014.06.034 · Cited by 654
Defective DNA Repair and Neurodegenerative Disease
Rass, U., Ahel, I., & West, S. C. (2007) · Cell · doi:10.1016/j.cell.2007.08.043 · Cited by 358 · cited 1×
“Defective DNA repair in post-mitotic neurons is an emerging causative factor of cognitive decline in neurodegenerative diseases (Madabhushi et al., 2014; Madabhushi et al., 2015; Rass et al., 2007).”
BackgroundDNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases
Bettencourt, C., Hensman‐Moss, D., Flower, M., Wiethoff, S., Brice, A., Goizet, C., Stevanin, G., Koutsis, G., Karadima, G., Panas, M., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24656 · Cited by 227
The HD iPSC Consortium, Lim, R. G., Salazar, L. L., Wilton, D. K., King, A. R., Stocksdale, J. T., Sharifabad, D., Lau, A. L., Stevens, B., Reidling, J. C., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4532 · Cited by 221
Self-citation
Research works printed but not linked: 49
- Bae, 2005, p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease, Neuron, 47, 29, 10.1016/j.neuron.2005.06.005 · DOI · Paper page
- Bertoni, 2011, Early and late events induced by polyQ-expanded proteins: identification of a common pathogenic property of polYQ-expanded proteins, The Journal of Biological Chemistry, 286, 4727, 10.1074/jbc.M110.156521 · DOI · Paper page
- Burnett, 2003, The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity, Human Molecular Genetics, 12, 3195, 10.1093/hmg/ddg344 · DOI · Paper page
- Chai, 2004, Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways, Journal of Biological Chemistry, 279, 3605, 10.1074/jbc.M310939200 · DOI · Paper page
- Chakraborty, 2015, Neil2-null mice accumulate oxidized DNA bases in the transcriptionally active sequences of the genome and are susceptible to innate inflammation, Journal of Biological Chemistry, 290, 24636, 10.1074/jbc.M115.658146 · DOI
- Chakraborty, 2016, Classical non-homologous end-joining pathway utilizes nascent RNA for error-free double-strand break repair of transcribed genes, Nature Communications, 7, 10.1038/ncomms13049 · DOI · Paper page
- Chatterjee, 2015, The role of the mammalian DNA End-processing enzyme polynucleotide kinase 3’-Phosphatase in Spinocerebellar Ataxia Type 3 Pathogenesis, PLOS Genetics, 11, 10.1371/journal.pgen.1004749 · DOI
- Cong, 2005, Mutant huntingtin represses CBP, but not p300, by binding and protein degradation, Molecular and Cellular Neuroscience, 30, 12, 10.1016/j.mcn.2005.05.003 · DOI
- Dunah, 2002, Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease, Science, 296, 2238, 10.1126/science.1072613 · DOI · Paper page
- Gao, 2015, Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3, PLOS Genetics, 11, 10.1371/journal.pgen.1004834 · DOI
- Giralt, 2012, Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity, Human Molecular Genetics, 21, 1203, 10.1093/hmg/ddr552 · DOI · Paper page
- Giuliano, 2003, DNA damage induced by polyglutamine-expanded proteins, Human Molecular Genetics, 12, 2301, 10.1093/hmg/ddg242 · DOI
- Hanawalt, 2008, Transcription-coupled DNA repair: two decades of progress and surprises, Nature Reviews Molecular Cell Biology, 9, 958, 10.1038/nrm2549 · DOI · Paper page
- Huang, 1998, Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins, Somatic Cell and Molecular Genetics, 24, 217, 10.1023/B:SCAM.0000007124.19463.e5 · DOI · Paper page
- Igarashi, 2003, Inducible PC12 cell model of Huntington’s disease shows toxicity and decreased histone acetylation, Mol Neuroscience, 14, 565, 10.1097/01.wnr.0000062604.01019.e1 · doi:10.1097/01.wnr.0000062604.01019.e1
- Illuzzi, 2009, DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates, Journal of Neuroscience Research, 87, 733, 10.1002/jnr.21881 · DOI · Paper page
- Jiang, 2003, Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein, Human Molecular Genetics, 12, 1, 10.1093/hmg/ddg002 · DOI · Paper page
- Jimenez-Sanchez, 2017, Huntington’s disease: Mechanisms of pathogenesis and therapeutic strategies, Cold Spring Harbor Perspectives in Medicine, 2017, 10.1101/cshperspect.a024240 · DOI · Paper page
- Karimi-Busheri, 1999, Molecular characterization of a human DNA kinase, Journal of Biological Chemistry, 274, 24187, 10.1074/jbc.274.34.24187 · DOI · Paper page
- Kumar, 2014, Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasis, Drug Discovery Today, 19, 956, 10.1016/j.drudis.2014.03.016 · DOI · Paper page
- Li, 1995, A huntingtin-associated protein enriched in brain with implications for pathology, Nature, 378, 398, 10.1038/378398a0 · DOI · Paper page
- Luthi-Carter, 2003, Mechanisms of transcriptional dysregulation in Huntington's disease, Clinical Neuroscience Research, 3, 165, 10.1016/S1566-2772(03)00059-8 · DOI
- MACDONALD, 1993, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes, Cell, 72, 971, 10.1016/0092-8674(93)90585-E · DOI · Paper page
- Mandal, 2012, Role of human DNA glycosylase Nei-like 2 (NEIL2) and single strand break repair protein polynucleotide kinase 3'-phosphatase in maintenance of mitochondrial genome, Journal of Biological Chemistry, 287, 2819, 10.1074/jbc.M111.272179 · DOI · Paper page
- McCampbell, 2000, CREB-binding protein sequestration by expanded polyglutamine, Human Molecular Genetics, 9, 2197, 10.1093/hmg/9.14.2197 · DOI · Paper page
- Menalled, 2012, Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175, PLOS ONE, 7, 10.1371/journal.pone.0049838 · DOI · Paper page
- Nucifora, 2001, Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity, Science, 291, 2423, 10.1126/science.1056784 · DOI · Paper page
- Olive, 2006, The comet assay: a method to measure DNA damage in individual cells, Nature Protocols, 1, 23, 10.1038/nprot.2006.5 · DOI · Paper page
- Orr, 2008, N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking, Journal of Neuroscience, 28, 2783, 10.1523/JNEUROSCI.0106-08.2008 · DOI · Paper page
- Poulton, 2013, Progressive cerebellar atrophy and polyneuropathy: expanding the spectrum of PNKP mutations, Neurogenetics, 14, 43, 10.1007/s10048-012-0351-8 · DOI
- Ross, 2011, Huntington's disease: from molecular pathogenesis to clinical treatment, The Lancet Neurology, 10, 83, 10.1016/S1474-4422(10)70245-3 · DOI · Paper page
- Sailaja, 2012, Chromatin immunoprecipitation in mouse hippocampal cells and tissues, Methods in Molecular Biology, 809, 353, 10.1007/978-1-61779-376-9_24 · DOI
- Santos, 2006, Quantitative PCR-based measurement of nuclear and mitochondrial DNA damage and repair in mammalian cells, Methods in Molecular Biology, 314, 183, 10.1385/1-59259-973-7:183 · DOI · Paper page
- Schilling, 1999, Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin, Human Molecular Genetics, 8, 397, 10.1093/hmg/8.3.397 · DOI · Paper page
- Schmitt, 2007, Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination, Biochemical and Biophysical Research Communications, 362, 734, 10.1016/j.bbrc.2007.08.062 · DOI · Paper page
- Shen, 2010, Mutations in PNKP cause microcephaly, seizures and defects in DNA repair, Nature Genetics, 42, 245, 10.1038/ng.526 · DOI · Paper page
- Shirendeb, 2011, Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage, Human Molecular Genetics, 20, 1438, 10.1093/hmg/ddr024 · DOI · Paper page
- Siddiqui, 2012, Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease, Free Radical Biology and Medicine, 53, 1478, 10.1016/j.freeradbiomed.2012.06.008 · DOI · Paper page
- Steffan, 2000, The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription, PNAS, 97, 6763, 10.1073/pnas.100110097 · DOI · Paper page
- Suhr, 2001, Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression, The Journal of Cell Biology, 153, 283, 10.1083/jcb.153.2.283 · DOI · Paper page
- Takeshita, 2011, Interaction of ataxin-3 with huntingtin-associated protein 1 through josephin domain, NeuroReport, 22, 232, 10.1097/WNR.0b013e32834505f4 · doi:10.1097/wnr.0b013e32834505f4
- Tanaka, 2006, Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin, Neurobiology of Disease, 21, 381, 10.1016/j.nbd.2005.07.014 · DOI
- Telezhkin, 2016, Forced cell cycle exit and modulation of GABAA, CREB, and GSK3β signaling promote functional maturation of induced pluripotent stem cell-derived neurons, American Journal of Physiology-Cell Physiology, 310, C520, 10.1152/ajpcell.00166.2015 · DOI
- Valor, 2015, Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective, Molecular Neurobiology, 51, 406, 10.1007/s12035-014-8715-8 · DOI
- Vonsattel, 1998, Huntington disease, Journal of Neuropathology and Experimental Neurology, 57, 369, 10.1097/00005072-199805000-00001 · DOI · Paper page
- Wiederhold, 2004, AP endonuclease-independent DNA base excision repair in human cells, Molecular Cell, 15, 209, 10.1016/j.molcel.2004.06.003 · DOI · Paper page
- Wyttenbach, 2001, Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease, Human Molecular Genetics, 10, 1829, 10.1093/hmg/10.17.1829 · DOI · Paper page
- Xh, 2014, Targeting ATM ameliorates mutant huntingtin toxicity in cell and animal models of Huntington’s disease, Science Translational Medicine, 268, 10.1126/scitranslmed.3010523 · DOI · Paper page
- Zhai, 2005, In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets, Cell, 123, 1241, 10.1016/j.cell.2005.10.030 · DOI · Paper page
Cited by
The central role of DNA damage in the ageing process
Schumacher, B., Pothof, J., Vijg, J., & Hoeijmakers, J. H. J. (2021) · Nature · doi:10.1038/s41586-021-03307-7 · Cited by 907
Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease
Welch, G., & Tsai, L. (2022) · The EMBO Reports · doi:10.15252/embr.202154217 · Cited by 129
Transcription Blockage by DNA Damage in Nucleotide Excision Repair-Related Neurological Dysfunctions
Kajitani, G. S., Nascimento, L. L. D. S., Neves, M. R. D. C., Leandro, G. D. S., Garcia, C. C. M., & Menck, C. F. M. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.10.009 · Cited by 22
Metadata
- Authors
- Gao, R., Chakraborty, A., Geater, C., Pradhan, S., Gordon, K. L., Snowden, J., Yuan, S., Dickey, A. S., Choudhary, S., Ashizawa, T., Ellerby, L. M., La Spada, A. R., Thompson, L. M., Hazra, T. K., & Sarkar, P. S.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2019-04-17
- Volume
- 8
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W2936437073
- Cited by
- 119
- References
- 11
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0/ (am)
- creativecommons.org/licenses/by/4.0/ (tdm)
- Funders
- NIH Office of the Director (NSO79541-01, EY026089-01A1, NS100529, AG033082, NS065874, NS089076, NS090390, NS073976)
- Hereditary Disease Foundation (Postdoctoral Fellowship)
- Mitchel Center for Neurodegenerative Diseases, University of Texas Medical Branch (Intramural Developmental Grant)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.